Yunjia Qu

Yunjia Qu

Auto-generated profile, based on publicly available information

Yunjia Qu

University of Southern California

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in Materials Today Bio
Verified
Journal Article
Open access
MTMin Tang
Min Tang
YQYunjia Qu
Yunjia Qu
PHPeixiang He
Peixiang He
EYEmmie Yao
Emmie Yao
TGTianze Guo
Tianze Guo
SCShaochen Chen
Shaochen Chen
Glioblastoma (GBM) presents a significant therapeutic challenge due to the limited efficacy of existing treatments. Chimeric antigen receptor (CAR) T-cell therapy offers promise, but its potential in solid tumors like GBM is undermined by the physical barrier posed by the extracellular matrix (ECM). To address the inadequacies of traditional 2D cell culture, animal models, and Matrigel-based 3D culture in mimicking the mechanical characteristics of tumor tissues, we employed biomaterials and digital light processing-based 3D bioprinting to fabricate biomimetic tumor models with finely tunable ECM stiffness independent of ECM composition. Our results demonstrated that increased material stiffness markedly impeded CAR-T cell penetration and tumor cell cytotoxicity in GBM models. The 3D bioprinted models enabled us to examine the influence of ECM stiffness on CAR-T cell therapy effectiveness, providing a clinically pertinent evaluation tool for CAR-T cell development in stiff solid tumors. Furthermore, we developed an innovative heat-inducible CAR-T cell therapy, effectively overcoming the challenges posed by the stiff tumor microenvironment.

21 November 2025 in Mechanobiology in Medicine
Verified
Journal Article
Open access
YQYunjia Qu
Yunjia Qu
JCJiaxin Cui
Jiaxin Cui
ZWZhuohang Wu
Zhuohang Wu
PHPeixiang He
Peixiang He
FWFan Wei
Fan Wei
LLLongwei Liu
Longwei Liu
Cancer cell memory, the ability to retain responses to prior environmental stimuli, has emerged as a key driver of tumor progression, therapeutic resistance, and immune evasion. Mechanical cues within the tumor microenvironment (TME), including matrix stiffness, viscoelasticity, and compressive stress, are increasingly recognized as critical regulators of such memory. These biophysical inputs not only influence immediate cellular behavior but also induce long-lasting transcriptional, epigenetic, and phenotypic changes that sustain cancer cell aggressive traits. In this review, we specifically highlight mechanobiology in shaping cancer cell memory. We summarize how extracellular matrix (ECM) composition and remodeling encodes mechanical inputs into stable gene expression programs that promote tumor progression, and highlight how mechano-regulated plasticity, membrane tension, chromatin remodeling, and epigenetic changes govern self-renewal, differentiation, and drug and immune resistance, underscoring how physical suppression contributes to chemo-, radio-, and targeted therapies failure. We further discuss emerging mechano-targeted strategies, including ECM-degrading agents, sonogenetic engineered cells, and stiffness-responsive nanoparticles, that seek to rewire cancer cell memory and improve treatment outcomes.

11 June 2026
Verified
Conference Paper
Closed access
PWPeter Yingxiao Wang
Peter Yingxiao Wang
CYChi Woo Yoon
Chi Woo Yoon
YQYunjia Qu
Yunjia Qu
FWFan Wei
Fan Wei
This webinar discusses what sono-mechanogenetics is and the application of this novel technology in oncology and beyond.